Company / Current Liabilities per Share
Adaptive Biotechnologies Corp Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.61
FY2025
5-year range
$0.61 / $0.83
FY2021-FY2025
Trend
-10.0%
vs FY2024
Sector context
#142 of 210
Health Care
What the data says
At $0.61, Adaptive Biotechnologies Corp's current liabilities per share ranks #69 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 8 years, ranging from $0.61 in FY2025 to $6.10 in FY2019.
Based on SEC 10-K filings.
0.61 in FY2025 with a 5-year CAGR of -6.2%.
Remained stable around $0.61 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -6.2%
- 10-Year CAGR
- -
Sector benchmark
-96.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 10.0% year-over-year.
- Ranks #142 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.61 | -10.0% |
| FY2024 | $0.68 | +9.9% |
| FY2023 | $0.62 | -20.8% |
| FY2022 | $0.78 | -6.1% |
| FY2021 | $0.83 | -1.6% |
| FY2020 | $0.84 | -86.2% |
| FY2019 | $6.10 | +237.8% |
| FY2018 | $1.81 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026